Icon Back Back to Search Results

STHLM3 AS NorDCaP - a Followup Study of Men on Active Surveillance of Prostate Cancer

  • Completed
  • Observational
  • Diagnostic Test
  • Karolinska Institutet
  • 40 - 75 Years

Study Purpose

The aim of the STHLM3 AS NorDCaP study is to evaluate the Stockholm3 test in an active surveillance cohort to predict upgrading on rebiopsy. The study follows a paired design, evaluating our proposed protocol for follow up men on active surveillance with Stockholm3 versus the standard protocol according to national guidelines with PSA.

Intervention

Diagnostic Test : Stockholm3 test

Eligibility Requirements

info icon Men diagnosed with low-risk PC and currently on AS and planned for follow-up with systematic and/or fusion biopsies as following standard of care.

info icon Minimum age: 40

info icon History of treatment for prostate cancer; surgery, radiation, chemotherapy or hormonal treatment.

info icon Severe illnesses such as metastatic cancers, severe cardio-vascular disease or dementia

Recruiting status

Completed

Estimated enrollment

199

 
Study start date

Jul 01, 2019

Study end date

Jul 01, 2024

Last updated

Mar 24, 2025

Primary purpose

N/A

Design

Observational

Intervention

Diagnostic Test

Study phase

N/A

Allocation

N/A

 

Sponsor:

Karolinska Institutet

Collaborator:

Helse Stavanger HF

University of Aarhus

Mehiläinen, Finland

Capio Sankt Görans Hospital

Investigator:

N/A

N/A

Publications

N/A


Websites

N/A

NCT04627948

Clinic Location Investigator Distance RECRUITING STATUS Contact